Anavex Life Sciences Corp expected to post a loss of 17 cents a share - Earnings Preview

Anavex Life Sciences

10/02/2025 13:35

* Anavex Life Sciences Corp  AVXL.OQ   AVXL.O  is expected
to show
no change in quarterly revenue when it reports  results on
February 12 for the period ending December 31 2024
    * 
    * ​LSEG's mean analyst estimate for Anavex Life Sciences
Corp is
for a loss of 17 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Anavex Life
Sciences Corp is $41.45​, above​ its last closing price
of $8.51. ​​​

This summary was machine generated February 10 at 13:35 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)